Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a
leading cause of cancer-related death worldwide. In the United States, HCC is the ninth …

These recommendations provide a data-supported approach to the diagnosis, staging and
treatment of patients diagnosed with hepatocellular carcinoma (HCC). They are based on …

Objectives Serous cystic neoplasm (SCN) is a cystic neoplasm of the pancreas whose
natural history is poorly known. The purpose of the study was to attempt to describe the …

Most patients with hepatocellular carcinoma (HCC) have liver cirrhosis, which develops
following long periods of chronic liver disease. Cirrhosis is characterized by a decrease in …

Recent years have seen significant progress in the systemic treatment of hepatocellular
carcinoma (HCC), including the advent of immunotherapy. While several large phase III …

Introduction of effective combined antiretroviral therapy has made HIV infection a chronic
illness. Substantial reductions in the number of AIDS-related deaths have been …

The incidence of AIDS-defining cancers (ADCs)–Kaposi sarcoma, primary central nervous
system lymphoma, non-Hodgkin lymphoma, and cervical cancer–although on the decline …

The recommendations provided in this document provide a data-supported approach to the
diagnosis, staging and treatment of patients diagnosed with hepatocellular carcinoma …

Background: The advent of highly active antiretroviral therapy (HAART) in 1996 led to a
decrease in the incidence of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma (NHL) …

Background: Monitoring the full spectrum of causes of death among persons with AIDS is
increasingly important as survival improves because of highly active antiretroviral therapy …